CASP3 and neoplasm: IHC (Fig. 3e) was used to assess the expression of PCNA, BCL-2, and cleaved caspase-3 in tumor tissues, revealing decreased expression of PCNA and BCL-2 and increased expression of cleaved caspase-3.